ClinicalTrials.gov
public full text
Public Domain
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression
The purpose of the study is to determine whether interferon-alpha is effective in prevention of tumor recurrence for the patients with a low miR-26 expression in tumor after curative resection of hepatocellular carcinoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection#801560
- Antiviral Therapy for Patients With Liver Cancer After Surgery#980013
- Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL#917068
- Randomized Phase III of PRRT Versus Interferon#803293
- UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.#1308161
Record · ID 1261121
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive